Cigdem Alkan

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Induced Apoptosis

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Cigdem Alkan, Terrence O'Brien, Victor Kenyon, Tetsuro Ikegami
Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus. Viruses 16 (1) (2024)
Cigdem Alkan, Eduardo Jurado-Cobena, Tetsuro Ikegami
Distinct Pathological Changes in Preweaning Mice Infected with Live-Attenuated Rift Valley Fever Virus Strains. Viruses 16 (7) (2024)
Cigdem Alkan, Terrence O'Brien, Victor Kenyon, Tetsuro Ikegami
Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus. Viruses 16 (1) (2024)
Cigdem Alkan, Terrence O'Brien, Victor Kenyon, Tetsuro Ikegami
Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus. Viruses 16 (1) (2024)
Cigdem Alkan, Terrence O'Brien, Victor Kenyon, Tetsuro Ikegami
Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus. Viruses 16 (1) (2024)
Cigdem Alkan, Eduardo Jurado-Cobena, Tetsuro Ikegami
Distinct Pathological Changes in Preweaning Mice Infected with Live-Attenuated Rift Valley Fever Virus Strains. Viruses 16 (7) (2024)
Cigdem Alkan, Terrence O'Brien, Victor Kenyon, Tetsuro Ikegami
Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus. Viruses 16 (1) (2024)
Cigdem Alkan, Eduardo Jurado-Cobena, Tetsuro Ikegami
Distinct Pathological Changes in Preweaning Mice Infected with Live-Attenuated Rift Valley Fever Virus Strains. Viruses 16 (7) (2024)
Cigdem Alkan, Eduardo Jurado-Cobena, Tetsuro Ikegami
Advancements in Rift Valley fever vaccines: a historical overview and prospects for next generation candidates. NPJ vaccines 8 (1) (2023)
Tetsuro Ikegami, Eduardo Jurado-Cobena, Cigdem Alkan, Jennifer K Smith, Lihong Zhang, Birte Kalveram, Terry L Juelich, Allen T Esterly, Jahnavi R Bhaskar, Saravanan Thangamani, Alexander N Freiberg
Evaluations of rationally designed rift valley fever vaccine candidate RVax-1 in mosquito and rodent models. NPJ vaccines 7 (1) (2022)